🔗 Share this article

Chancellor Rachel Reeves has stated she is planning "targeted action to tackle cost of living issues" in the forthcoming financial statement.

In comments to media outlets, she noted that reducing inflation is a collective duty of both the administration and the central bank.

The UK's price growth is forecast to be the highest among the G7 advanced economies this year and next.

Potential Utility Bill Interventions

Reports indicate the administration could take action to lower energy bills, for instance by slashing the current 5% level of value-added tax applied on energy.

An additional approach is to reduce some of the policy costs presently added to household expenses.

Fiscal Limitations and Expert Expectations

The administration will receive the latest report from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much room there is for such actions.

The expectation from most experts is that the Chancellor will have to declare tax increases or spending cuts in order to adhere to her declared borrowing rules.

Earlier on Thursday, estimates showed there was a £22 billion deficit for the chancellor to resolve, which is at the more modest range of expectations.

"It is a shared job between the central bank and the administration to further reduce some of the causes of inflation," Reeves informed the BBC in the US capital, at the annual meetings of the IMF and global financial institution.

Revenue Pledges and Global Concerns

While much of the attention has been on likely tax increases, the chancellor said the most recent figures from the OBR had not altered her vow to campaign commitments not to raise tax levels on income tax, sales tax or National Insurance.

She attributed an "unpredictable world" with growing geopolitical and commercial issues for the Budget tax moves, likely to be focused on those "wealthiest."

International Trade Tensions

Referring to concerns about the United Kingdom's trade ties with China she said: "The UK's security interests always take priority."

Last week's statement by Chinese authorities to increase export controls on critical minerals and other resources that are crucial for advanced tech production led US President Donald Trump to suggest an extra 100% tariff on goods from China, raising the possibility of an all-out trade war between the two global powers.

The American finance chief labeled the Chinese decision "economic coercion" and "a international production control attempt."

Questioned on accepting the American proposal to participate in its battle with China, Reeves said she was "extremely troubled" by Chinese measures and urged the Beijing authorities "not to put up barriers and limit trade."

She said the decision was "bad for the world economy and creates further challenges."

"I believe there are areas where we should challenge Chinese policies, but there are also important chances to export to Chinese markets, including financial services and other areas of the economy. We've got to maintain that equilibrium correct."

The Treasury chief also confirmed she was collaborating with G7 counterparts "regarding our own essential resources approach, so that we are less reliant."

Health Service Medicine Pricing and Investment

Reeves also recognized that the price the National Health Service spends on pharmaceuticals could increase as a result of ongoing talks with the Trump administration and its pharmaceutical firms, in return for lower tariffs and funding.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either halting or canceling investments in the United Kingdom, with several blaming the low prices they are receiving.

Last month, the government science advisor said the cost the health service pays for medicines would must go up to prevent companies and pharmaceutical investment leaving the United Kingdom.

Reeves stated to media: "We have seen because of the pricing regime, that medical research, recent pharmaceuticals have not been available in the UK in the way that they are in other continental states."

"We want to guarantee that people getting treatment from the NHS are able to receive the best critical drugs in the world. And so we are examining all of that, and... looking to secure increased capital into the UK."